Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
AEMETIS, INC (AMTX)
Standardized SEC financial data for AEMETIS, INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000738214 · NASDAQ · Industrial Organic Chemicals.
Income statement
USD
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$165.6M
$211.9M
$256.5M
$186.7M
$267.6M
$197.6M
Cost of revenue
$154.5M
$204.0M
$262.0M
$184.7M
$268.2M
$208.7M
Gross profit
$11.0M
$7.9M
-$5.5M
$2.0M
-$580K
-$768K
R&D expense
$213K
$88K
$180K
$152K
—
—
SG&A expense
$16.9M
$23.7M
$28.7M
$39.4M
$39.8M
$36.5M
Operating income
-$6.1M
-$15.8M
-$34.4M
-$37.4M
-$40.4M
-$37.2M
EBITDA
-$1.2M
-$10.4M
—
—
-$32.0M
-$27.6M
Interest expense
$22.9M
$24.1M
$28.8M
$39.5M
$46.6M
$52.9M
Pretax income
-$37.6M
-$47.3M
-$106.7M
-$100.2M
-$98.4M
-$95.7M
Income tax
$976K
$128K
$1.1M
$53.7M
$10.8M
$18.7M
Net income
-$36.7M
-$47.1M
-$107.8M
-$46.4M
-$87.5M
-$77.0M
EPS (diluted)
$-1.74
$-1.54
$-3.12
$-1.22
$-1.91
$-1.28
Standardized from AEMETIS, INC's SEC filings — per-share figures split-adjusted. Full history via the API.